Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials.

Simon J Gunter Martina L Porter Alexa B Kimball

Int J Womens Dermatol

Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Published: October 2024

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338249	PMC
http://dx.doi.org/10.1097/JW9.0000000000000171	DOI Listing

Publication Analysis

Top Keywords

placebo responders

responders moderate-to-severe

moderate-to-severe hidradenitis

hidradenitis suppurativa

suppurativa experience

experience declines

declines inflammation

inflammation measured

measured c-reactive

c-reactive protein

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!